Возможности современных методик визуализации при ишемической болезни сердца

Обложка

Цитировать

Полный текст

Аннотация

Сегодня в науке и клинической практике большой критике подвергается «механистическая» теория ишемической болезни сердца (ИБС), основной концепцией которой является прямая корреляция между процентом стенотического сужения коронарной артерии и степенью ишемии миокарда в зоне, кровоснабжаемой данным сосудом. Практически каждый опытный кардиолог сталкивался со случаями, в которых при визуально значительном сужении коронарной артерии, по данным коронарной ангиографии, кровоснабжение данного участка не столь выраженно страдало (по данным методик визуализации в ходе индукции ишемии). В связи с этим оценке функциональной значимости стенозов сегодня в науке уделяется большое внимание, и с течением времени это зачастую становится краеугольным камнем в выборе пути лечения пациентов с ИБС.Необходимость выбора наиболее информативной в каждом клиническом случае методики для верификации диагноза и определения дальнейшей тактики ведения определяется необходимостью индивидуального подхода при выборе методики лечения у пациентов с ИБС, основанного на совокупности данных анатомии коронарного русла и функционального состояния миокарда, что может значительно улучшить исход и отдаленный результат лечения.

Об авторах

Юрий Иосифович Бузиашвили

ФГБУ Научный центр сердечно-сосудистой хирургииим. А.Н.Бакулева

д-р мед.наук, проф., зам.дир. по науч. работе Института кардиохирургии им. В.И.Бураковского, рук.КДОФГБУ НЦССХ им. А.Н.Бакулева, акад.РАН

Виктория Юрьевна Бузиашвили

ФГБУ Научный центр сердечно-сосудистой хирургииим. А.Н.Бакулева

аспирант КДО ФГБУ НЦССХ им. А.Н.Бакулева

Список литературы

  1. ВОЗ, 2011.
  2. Bax J.J, Wijns W, Cornel J.H. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997; 30: 1451-60.
  3. Schinkel A.F.L, Bax J.J, Geleijnse M.L et al. Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography? Eur Heart J 2003; 24: 789-800.
  4. Beleslin B.D, Ostojic M, Djordjevic-Dikic A et al. Integrated evaluation of relation between coronary lesion features and stress echocardiography results: the importance of coronary lesion morphology. J Am Coll Cardiol 1999; 33: 717-26.
  5. Blankstein R, Shturman L.D, Rogers I.S. et al. Adenosine - induced stress myocardial perfusion imaging using dual - source cardiac computed tomography. J Am Coll Cardiol 2009; 54: 1072-84.
  6. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 1971; 27: 416-32.
  7. Carr C.L, Lindner J.R. Myocardial perfusion imaging with contrast echocardiography. Curr Cardiol Rep 2008; 10: 233-9.
  8. Chopra H.K. Myocardial contrast echocardiography: a new tool for assesment of myocardial perfusion. Indian Heart J 2009; 61(1): 8-13.
  9. Dijkmans P.A, Senior R, Becher Het al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol 2006; 48: 2168-77.
  10. Eur Heart J 2010; 31 (20): 2501-55; doi: 10.1093/eurheartj/ ehq277
  11. Wijns W, Kolh P, Danchin Net al.European Association for Percutaneous Cardiovascular Interventions (EAPCI).
  12. George R.T, Arbab-Zadeh A, Miller J.M et al. Adenosine Stress 64- and 256-row detector computed tomography angiography and perfusion imaging: clinical perspective. Circ Cardiovasc Imaging 2009; 2: 174-82.
  13. Gerber B.L, Ordoubadi F.F, Wijns Wet al. Positron emission tomography using18F-fluoro - deoxyglucose and euglycaemichyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post - ischaemic left ventricular dysfunction. Results from the European Community concerted action multicenter study on use of18F- fluoro - deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 2001; 22: 1691-701.
  14. Gerber B.L, Raman S.V, Nayak Ket al. Myocardial first - pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson 2008; 10: 18.
  15. Garcia-Garcia H.M, Costa M.A, Serruys P.W. Imaging of coronary atherosclerosis: intravascular ultrasound. Eur Heart J 2010; 31: 2456-69.
  16. Gibbons R.J, Abrams J, Chatterjee K et al. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee on the Management of Patients with Chronic Stable Angina. ACC/AHS 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation 2003; 107: 149-58.
  17. Gibbons R.J, Abrams J, Chatterjee K, Daley J, Deedwania P.C, Douglas J.S, Ferguson T.B.Jr, Fihn S.D, Fraker T.D Jr, Gardin J.M, O'Rourke R.A, Pasternak R.C, Williams S.V, Gibbons R.J, Alpert J.S, Antman E.M, Hiratzka L.F, Fuster V, Faxon D.P, Gregoratos G, Jacobs A.K, Smith S.C.Jr; American Collegeof Cardiology; American Heart Association Task Forceon Practice Guidelines. Committee on the Management of Patient swith Chronic Stable Angina. ACC/AHS 2002 guideline update for the management of patient swith chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task- Forceon Practice Guidelines (Committee on the Management of Patient swith Chronic Stable Angina). Circulation. 2003; 107: 149-158.).
  18. Hachamovitch R, Hayes S, Friedman J.D. et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003; 41: 1329-40.
  19. Hamon M, Fau G, Nee G et al. Meta - analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010; 12: 29.
  20. Ioannidis J.P.A, Trikalinos T.A, Danias P.G. Electrocardiogram - gated single - photonemission computed tomography versus cardiacmagnetic resonance imaging for the assessmentof left ventricular volumes and ejection fraction: A meta - analysis. J Am Coll Cardiol 2002; 39: 2059-68.
  21. Jonathan R Lindner. Perfusion imaging with vasodilator stress echocardiography a physiologically sound approach to coronary disease? Circulation: Cardiovascular Imaging 2011; 4 (6): 601-3.
  22. Josef Machac. PET myocardialperfusionimaging. Seminars in Nuclear Medicine (Impact Factor: 3.82). 2005; 35 (1): 17-36.
  23. Justine Varieur Cadet, CT perfusion has better overall benefits compared with SPECT. J Am Coll Cardiol2009.
  24. Kim R.J, Wu E, Rafael Aet al. The use of contrast - enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.
  25. McCully R.B, Roger V.L, Mahoney D.W. et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow - up of 1325 patients. J Am Coll Cardiol 1998; 31: 144-9.
  26. Naghavi M, Libby P, Falk Eet al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003; 108: 1664-72.
  27. Nandalur K.R, Dwamena B.A, Choudhri A.F. et al. Diagnostic performance of positron emission tomography in the detection of coronary artery disease: a meta - analysis. Acad Radiol 2008.
  28. Natale L, Meduri A, Caltavuturo Cet al. MRI assessment of ventricular function. Rays 2001; 26: 35-44.
  29. Shaw L.J, Berman D.S, Maron D.J. et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-91.
  30. Pakkal M,Raj V, McCann G.P. Non - invasive imaging in coronary artery disease including anatomical and functional evaluation of ischaemia and viability assessment. Br J Radiol 2011; 84 (3): S280-95.
  31. Pijls N.H, De Bruyne B, Peels Ket al. Measurement of fractional flow reserve to assess the functional severity of coronary - artery stenoses. N Engl J Med 1996; 334: 1703-8.
  32. Pijls N.H.J, van Schaardenburgh P, Manoharan G. et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5- year follow - up of the DEFER study. J Am Coll Cardiol 2007; 49: 2105-11.
  33. Slomka P.J. Integrated CT angiography and myocardial perfusion makes progress, Medscape, 2007.
  34. Schwitter J, Wacker C.M, van Rossum A.C. et al. MR-IMPACT: comparison of perfusion - cardiac magnetic resonance with single - photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008; 29: 480-9.
  35. Stamper D, Weissman N.J, Brezinski M. Plaque characterization with optical coherence tomography. J Am CollCardiol 2006; 47 (Suppl. 8): C69-79.
  36. Tahara N, Kai H, Ishibashi Met al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48: 1825-31.
  37. ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio - Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2014; 46 (4): 517-92; doi: 10.1093/ejcts/ezu366
  38. Tonino P.A.L, De Bruyne B, Pijls N.H.J. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-24.
  39. Underwood S.R, Anagnostopoulos C, Cerqueira Met al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004; 31: 261-91.
  40. Wagner A, Mahrholdt H, Holly T.A et al. Contrast - enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003; 361: 374-9.

© ООО "Эко-Вектор", 2014

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах